info@apparati.co | +44 7572327495
June 17, 2026 - BY Glossy

Wellness Briefing: How stem cell therapy innovator Acorn Biolabs is (legally) scaling in the US, plus news

For the Wellness Briefing, Glossy sat down with Drew Taylor, Ph.D, CEO and co-founder of Acorn Biolabs, a Canadian regenerative medicine company that turns one’s own hair follicles into stem cells for longevity- and aesthetic-focused therapies. The company is tapping U.S. doctors to scale its You secretome offering in the U.S. Additionally, functional fragrance has a new wellness player, the chief merchandising officer at CVS steps down, and Merrithew invests in emerging fitness modality gyrokinesis.